Læknablaðið - 15.09.1991, Blaðsíða 46

282
LÆKNABLAÐIÐ
14. Salzman EW, Rozenberg RD, Smith MH, Linden JN,
Favreau L. Effect of heparin and heparin fractions on
platelet aggregation. J Clin Invest 1980; 65: 64-73.
15. Green D. Heparin-induced thrombocytopenia. Med J
Aust (Heparin Supplement) 1986; 144; 37-9.
16. Weismann RE, Tobin RW. Arterial embolism
occurring during systemic heparin therapy. Arch Surg
1958; 76: 219-27.
17. Roberts B, Rosato FE, Rosato EF. Heparin - a cause
of arterial emboli? Surgery 1964; 55: 803-8.
18. Rhodes GR, Dixon RH, Silver D. Heparin induced
thrombocytopenia with thrombotic and hemorrhagic
manifestations. Surg Gynecol Obstet 1973; 136: 409-
16.
19. Rhodes GR, Dixon RH, Silver D. Heparin induced
thrombocytopenia: Eight cases with thrombotic-
hemorrhagic complications. Ann Surg 1977; 186:
752-8.
20. Silver D, Kapsch DN, Tsoi EKM. Heparin-induced
thrombocytopenia, thrombosis and hemorrhage. Ann
Surg 1983; 301-6.
21. Laster J, Cikrit D, Walkcr N, Silver D. The heparin-
induced thrombocytopenia syndrome: An update.
Surgery 1987; 102: 763-70.
22. Arthur CK. Isbister JP, Aspery EM. The heparin
induced thrombosis-thrombocytopenia syndrome
(H.I.T.T.S.); a review. Pathology 1985; 17: 82-6.
23. Ramirez-Lassepas M, Cipolle RJ, Rodvold KA, et
al. Heparin-induced thrombocytopenia in patients
with cerebrovascular ischemic disease. Neurology
(Cleveland) 1984; 34: 736-40.
24. Bell WR, Royall RM. Heparin- associated
thrombocytopenia: a comparison of three heparin
preparations. N Eng J Med 1980; 303: 902-7.
25. Ansell J, Stepchuk N, Kumar R, Lopez A, Southard
L. Deykin D. Heparin-induced thrombocytopenia: a
prospective study. Thromb Haemostas 1980; 43: 61-5.
26. Kwaan HC, Kampmeior PA, Gomez HZ. Incidence
of thrombocytopenia during therapy with bovine
lung and porcine gut heparin preparations. Thromb
Haemostas 1981; 46: 680 (abstr).
27. Powers PJ, Kelton JG, Carter CJ. Studies of the
frequency of heparin-associated thrombocytopenia.
Thromb Res 1984; 33: 439-43.
28. Rao AK, White GC, Sherman L, Colman R, Lan G,
Ball AP. Low incidcnce of thrombocytopenia with
porcine mucosal heparin. A prospective multicenter
study. Arch Intern Med 1989; 149: 1285-8.
29. Green D, Martin GJ, Shoichet SH, DeBackcr N,
Bomalaski JS, Lind RN. Thrombocytopenia in a
prospective, randomized, double-blind trial of bovine
and porcine heparin. Am J Med Sci 1984; 288: 60-4.
30. Horellou MH, Conard J, Lecrubier C, et al. Persistent
heparin-induced thrombocytopenia despite Iherapy
with low molecular weight heparin. Thromb
Haemostas 1984; 51: 134 (letter).
31. Leroy J, Leclerc MH, Delahousse B, et al. Treatment
of heparin-associated thrombocytopenia and
thrombosis with low molecular weight heparin
(CY2I6). Semin Thromb Hemost 1985; II: 326-9.
32. Vitoux JF, Mathieu JF, Roncato M, Fiessinger JN,
Aiach M. Heparin-associated thrombocytopcnia
treatment with low molecular weight heparin. Thromb
Haemostas 1986; 55: 37-9.
33. Chong BH, Ismail F, Cade J, Gallus AS, Gordon S,
Chesterman CN. Heparin-induced thrombocytopcnia:
Studies with a new low molecular weight hepainoid,
Org 10172. Blood 1989; 73: 1592-6.
34. Oriot D, Wolf M, Brun P, Sidi D, Devictor D,
Tchemia G, Huault G. Thrombopcnie severe induite
par l'hcparine chez un nourrisson porteur d'une
myocardite aigue. Arch Fr Pediatr 1990; 47: 357-9.
35. Heeger PS, Backstrom JT. Heparin flushes and
thrombocytopenia. Ann Intem Med 1986; 105: 143
(lettcr).
36. Laster JL, Nichols WK, Silver D. Thrombocytopenia
associated with heparin-coated catheters in patients
with heparin-associated antiplatclet antibodies. Arch
Intem Med 1989; 149: 2285-7.
37. Laster J. Silver D. Heparin-coated catheters and
heparin-induced thrombocylopenia. J Vasc Surg 1988;
7: 667- 72.
38. Case Records of the Massachussetts General Hospital
(Case 49-1989). N Engl J Med 1989; 321: 1595-
1603.
39. Dclhumeau A, Houet JF, Bourrier P. Bukowski JG,
Granry JC. Thrombopenies a l’heparine compliquees
d'hematome des surrenales et d'insuffisance
surrenalienne aigue. Ann Fr Anesth Reanim 1989:
8: 656-8.
40. O’Toole RD. Heparin: adverse reaction. Ann lntem
Med 1973; 79: 759.
41. White PW, Sadd JR, Nenses RE. Thrombotic
complications of heparin therapy including six cases
of heparin-induced skin necrosis. Ann Surg 1979;
190: 595-608.
42. Hartman AR, Hood M, Anagnostopoulos CE.
Phenontenon of heparin-induccd thrombocytopenia
associated with skin necrosis. J Vasc Surg 1988; 7:
781-4.
43. Celoria GM, Steingart RH, Bauson B, Friedman
P. Rhee SW, Berman JA. Coumarin induced
skin nccrosis in a patient witlt heparin-induced
thrombocytopenia - a case report. Angiology 1988;
39: 915-20.
44. Kroll MH, Schafer AI. Biochemical mechanisnts of
platelet activation. Blood 1989; 74: 1181-95.
45. Bennett JS, Shattil SJ. Plalelet function. In: Williams
WJ, Beutler E, Erslev AJ, Lichtman MA, eds.
Hematology, 4th ed. New York: McGraw-Hill, 1990:
1233-50.
46. George JN, Shattil SJ. The clinical importance of
acquired abnormalities of platelet function. N Eng J
Med 1991; 324: 27-39.
47. Fisher CA, Kappa JR, Sinha AK, Cottrell ED,
Reiser IIJ, Addonizio P. Comparison of equimolar
concentrations of iloprost, prostacyclin and
prostaglandin E1 on huntan platclet function. J Lab
Clin Med 1987; 109: 184-90.
48. Kappa JR, Fisher CA, Addonizio VP. Heparin-
induced platelet activation: The role of thromboxane
A2 synthesis and the extent of platelet granule release
in two patients. J Vasc Surg 1989; 9: 574-9.
49. Kelton JG, Sheridan D, Santos A, et al. Heparin-
induced thrombocytopenia: Laboratory studies. Blood
1988; 72: 925-30.
50. Sheridan D, Carter C, Kelton JG. A diagnostic test
for heparin-induced thrombocytopenia. Blood 1986;
67: 27-30.
51. Chong BH, Fawaz I, Chestcrman CN, Bemdt MC.
Heparin- induced thrombocytopenia: mechanisnt of
interaction of the heparin-dependent antibody with
platelets. Br J Hematol 1989; 73: 235-40.
52. Babcock RB, Dumper CW, Scharfman WB. Heparin-
induced immune thrombocytopcnia. N Eng J Med
1976; 295: 237-41.
53. Fratantoni JC, Pollet R, Gralnick HR. Heparin-